Related references
Note: Only part of the references are listed.Tracheoesophageal (TE) fistula development in a phase II trial of concurrent chemoradiation (CRT) and bevacizumab (B) in limited-stage small-cell lung cancer (LS-SCLC)
D. R. Spigel et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)
C. Le Pechoux et al.
ANNALS OF ONCOLOGY (2011)
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer
A. Schmittel et al.
ANNALS OF ONCOLOGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE Trial
David R. Spigel et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Randomized Phase II Trial of Single-Agent Amrubicin or Topotecan as Second-Line Treatment in Patients With Small-Cell Lung Cancer Sensitive to First-Line Platinum-Based Chemotherapy
Robert Jotte et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
Leena Gandhi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease
P. Zatloukal et al.
ANNALS OF ONCOLOGY (2010)
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Sorensen et al.
ANNALS OF ONCOLOGY (2010)
Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. Zucca et al.
ANNALS OF ONCOLOGY (2010)
Perspective on Updated Treatment Guidelines for Patients With Gastrointestinal Stromal Tumors
Jean-Yves Blay et al.
CANCER (2010)
SELECTIVE NODAL IRRADIATION ON BASIS OF (18)FDG-PET SCANS IN LIMITED-DISEASE SMALL-CELL LUNG CANCER: A PROSPECTIVE STUDY
Judith van Loon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Phase II Study of Amrubicin As Second-Line Therapy in Patients With Platinum-Refractory Small-Cell Lung Cancer
David S. Ettinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A Meta-Analysis of Randomized Controlled Trials Comparing Irinotecan/Platinum with Etoposide/Platinum in Patients with Previously Untreated Extensive-Stage Small Cell Lung Cancer
Jingwei Jiang et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Phase II Study of Sequential Triplet Chemotherapy, Irinotecan and Cisplatin Followed by Amrubicin, in Patients with Extensive-Stage Small Cell Lung Cancer: West Japan Thoracic Oncology Group Study 0301
Masashi Kobayashi et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Maintenance or consolidation therapy in small-cell lung cancer: A systematic review and meta-analysis
Antonio Rossi et al.
LUNG CANCER (2010)
Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501
Leora Horn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms-Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups
Berend J. Slotman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer
John R. Eckardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124
Primo N. Lara et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer
Mark A. Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
Siow Ming Lee et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer
David R. Spigel et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial
Cecile Le Pechoux et al.
LANCET ONCOLOGY (2009)
Radiotherapy for small-cell lung cancer-Where are we heading?
N. A. Bayman et al.
LUNG CANCER (2009)
A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer
Athanasios G. Pallis et al.
LUNG CANCER (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer
S. M. Lee et al.
THORAX (2009)
Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer
S. Baka et al.
BRITISH JOURNAL OF CANCER (2008)
Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer
Christine L. Hann et al.
CANCER RESEARCH (2008)
Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors
Paolo Ceppi et al.
CLINICAL CANCER RESEARCH (2008)
Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models
Alex R. Shoemaker et al.
CLINICAL CANCER RESEARCH (2008)
Hedgehog: functions and mechanisms
Markku Varjosalo et al.
GENES & DEVELOPMENT (2008)
Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer:: A Randomized phase III trial
Andreas Hermes et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cediranib (AZD2171) for the treatment of recurrent small cell lung cancer (SCLC): A California Consortium phase II study (NCI # 7097)
S. S. Ramalingam et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized phase II study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer:: CALGB 30103
Charles M. Rudin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sorafenib in patients with platinum (plat) treated extensive stage small cell lung cancer (E-SCLC): A SWOG (S0435) phase II trial
B. J. Gitlitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402
Akira Inoue et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The International Association for the study of Lung Cancer - Lung Cancer staging project: Proposals regarding the clinical staging of small cell Lung Cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for Lung Cancer
Frances A. Shepherd et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada clinical trials group study BR. 20
Andrew M. Arnold et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy:: An intergroup study FNCLCC cleo04-IFCT 00-01
Jean Louis Pujol et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prophylactic cranial irradiation in extensive small-cell lung cancer
Ben Slotman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Randomized phase II study of maintenance vandetanib (ZD6474) in small cell lung cancer (SCLC) patients who have a complete or partial response to induction therapy: NCIC CTG BR.20
A. M. Arnold et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Chemotherapy for relapsed small cell lung cancer: A systematic review and practice guideline
Susanna Cheng et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902
C. M. Rocha-Lima et al.
ANNALS OF ONCOLOGY (2007)
Management of small cell lung cancer - ACCP evidence-based clinical practice guidelines (2nd edition)
George R. Simon et al.
CHEST (2007)
Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study
Takashi Yana et al.
INVESTIGATIONAL NEW DRUGS (2007)
Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic oncology research group study 0301
Sayaka Onoda et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
Mary E. R. O'Brien et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer
Mark A. Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database
Ramaswamy Govindan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: A phase II trial
Dirk De Ruysscher et al.
RADIOTHERAPY AND ONCOLOGY (2006)
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: A Hoosier Oncology Group phase II trial
AM Moore et al.
LUNG CANCER (2006)
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
D De Ruysscher et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
SJ Antonia et al.
CLINICAL CANCER RESEARCH (2006)
Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma
FM Johnson et al.
CANCER (2006)
Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published randomized controlled trials
H Bozcuk et al.
CANCER (2005)
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein - A phase II clinical trial
LM Krug et al.
CANCER (2005)
Phase II trial of gemcitabine/irinotecan in refractory or relapsed small-cell lung cancer
Wolfgang Schuette et al.
CLINICAL LUNG CANCER (2005)
New targeted therapies in breast cancer
V Kaklamani et al.
SEMINARS IN ONCOLOGY (2004)
Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern cooperative oncology group trial 1597
GA Masters et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer
DN Watkins et al.
NATURE (2003)
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: Results from a randomized phase III trial with 5 years' follow-up
S Sundstrom et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Non-cross resistance of ZD0473 in acquired cisplatin-resistant lung cancer cell lines
Y Kawamura-Akiyama et al.
LUNG CANCER (2002)
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer
JP Sculier et al.
ANNALS OF ONCOLOGY (2002)
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
W Noda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Single-agent gemcitabine in patients with resistant small-cell lung cancer
I van der Lee et al.
ANNALS OF ONCOLOGY (2001)
Share Paper
